We understand that it can be upsetting when a clinical trial ends earlier than expected. Clinical trials can end early for many reasons. Sometimes researchers gather enough information sooner than planned and can decide that the treatment works well or that it doesn’t work as well as hoped. Other times, the trial may stop early because of funding or trouble making the drug. If your trial ends early, you can consider joining another trial. Read below to learn what steps you can take next and how to look for another trial that could be a fit for you.
What to Know and Do About Clinical Trials Ending Early
- AbbVie: When a clinical trial ends, the trial team will help you with next steps including transitioning to usual care
- Alzheimer’s Disease International: After a clinical trial ends, sometimes you can continue to receive the study medication
- Alzheimer’s Association: Trial participants are notified if their trial ends early
Looking for a New MBC Clinical Trial
- University of Alabama at Birmingham: There may be a waiting period to join a second trial after the first one is complete (scroll to questions on page 4 and 5)
- Metastatic Trial Search: Trials for People with MBC